ELEVATED SERUM GAMMA-GLUTAMYLTRANSFERASE IS AN ADVERSE PROGNOSTIC FACTOR IN CASTRATION-RESISTANT PROSTATE CANCER PATIENTS TREATED WITH ENZALUTAMIDE

被引：0
|
作者：
Takemura, Kosuke
Ito, Masaya
Nakanishi, Yasukazu
Kataoka, Madoka
Sakamoto, Kazumasa
Suzuki, Hiroaki
Iida, Noriyuki
Tobisu, Ken-ichi
Koga, Fumitaka
机构：
来源：
JOURNAL OF UROLOGY | 2019年 / 201卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP28-11
引用
收藏
页码：E407 / E408
页数：2
相关论文
共 50 条
  • [1] Serum γ-Glutamyltransferase as a Prognostic Biomarker in Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide
    Takemura, Kosuke
    Ito, Masaya
    Nakanishi, Yasukazu
    Kataoka, Madoka
    Sakamoto, Kazumasa
    Suzuki, Hiroaki
    Tobisu, Ken-ichi
    Koga, Fumitaka
    ANTICANCER RESEARCH, 2019, 39 (10) : 5773 - 5780
  • [2] Enzalutamide for Patients with castration-resistant Prostate Cancer
    Kessing, Richard
    AKTUELLE UROLOGIE, 2020, 51 (01)
  • [3] Enzalutamide in Castration-Resistant Prostate Cancer
    Bregni, Giacomo
    Rebuzzi, Sara E.
    Fornarini, Giuseppe
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (14): : 1380 - 1381
  • [4] Enzalutamide in castration-resistant prostate cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2014, 15 (08): : E312 - E312
  • [5] Enzalutamide for Patients with castration-resistant Prostate Cancer Comment
    Kretschmer, Alexander
    AKTUELLE UROLOGIE, 2020, 51 (01)
  • [6] Enzalutamide for patients with metastatic castration-resistant prostate cancer
    Ramadan, Wijdan H.
    Kabbara, Wissam K.
    Al Masri, Hiba S. Al Basiouni
    ONCOTARGETS AND THERAPY, 2015, 8 : 871 - 876
  • [7] Enzalutamide in Castration-Resistant Prostate Cancer Reply
    Hussain, Maha
    Saad, Fred
    Sternberg, Cora N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (14): : 1381 - 1381
  • [8] Enzalutamide: A Review in Castration-Resistant Prostate Cancer
    Lesley J. Scott
    Drugs, 2018, 78 : 1913 - 1924
  • [9] ENZALUTAMIDE FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER
    Ha, Y-S
    Goodin, S.
    DiPaola, R. S.
    Kim, I. Y.
    DRUGS OF TODAY, 2013, 49 (01) : 7 - 13
  • [10] Healthcare Costs for Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide
    Rana, Dikshyanta
    Geue, Claudia
    Baillie, Kelly
    Pan, Jiafeng
    Mueller, Tanja
    Laskey, Jennifer
    Bennie, Marion
    Clarke, Julie
    Jones, Robert J.
    Brown, Ailsa
    Wu, Olivia
    PHARMACOECONOMICS-OPEN, 2022, 6 (02) : 303 - 313
12345